NOVOZYMES A/S SPONS.ADR 1 (NZM) — Cash Flow Quality Index
NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Cash Flow Quality Index of 0.84x as of March 2026. Operating cash flow of €167.10 Million is below net income of €199.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NZM operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NOVOZYMES A/S SPONS.ADR 1 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for NOVOZYMES A/S SPONS.ADR 1 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see NOVOZYMES A/S SPONS.ADR 1 (NZM) cash conversion ratio.
Annual Cash Flow Quality Index for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
Year-by-year earnings quality comparison for NOVOZYMES A/S SPONS.ADR 1.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.09x | €1.22 Billion | €583.60 Million | ▲ +368.1% |
| 2024 | 0.45x | €1.02 Billion | €2.28 Billion | ▲ +142.7% |
| 2023 | 0.18x | €557.10 Million | €3.02 Billion | ▲ +26.0% |
| 2022 | 0.15x | €537.65 Million | €3.68 Billion | ▼ -88.7% |
| 2021 | 1.29x | €546.17 Million | €423.00 Million | — |